Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

"Gan & Lee Pharmaceuticals"Announcement on the Listing and Trading of Certain Restricted Shares from the Initial Public Offering

Aug 19, 2026 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

The total number of shares to be listed and traded is 259,327 shares, and the listing and trading date is August 24, 2026.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Gan & Lee Pharmaceuticals Co., Ltd. Class A

"Gan & Lee Pharmaceuticals"Announcement on Signing of the Authorization and License Agreement for the Bofanglutide Project with Menarini GroupAug 11
"Gan & Lee Pharmaceuticals"Announcement on Implementation of Repurchase and Cancellation of Certain Restricted Shares under the 2022 and 2024 Restricted Share Incentive PlansAug 8
"Gan & Lee Pharmaceuticals."Announcement on Shareholding Reduction Plan by Directors and Senior ManagementAug 7
"Gan & Lee Pharmaceuticals."Announcement on Completion of Registration of the Grant under the 2026 Restricted Share Incentive PlanJul 29

All Gan & Lee Pharmaceuticals Co., Ltd. Class A news releases